4G Vaccines Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A
  • (Cancelled)

  • Investors
  • 1

4G Vaccines General Information

Description

Developer of vaccines products. The company's vaccines focus on treatment of oncology and infectious diseases, enabling the medical industry to treat their patients in proper and better manner.

Contact Information

Website
www.4gvaccines.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Kronheimer Building
  • Heidelberg, Victoria 3084
  • Australia
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Stamford Pharmaceuticals
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Kronheimer Building
  • Heidelberg, Victoria 3084
  • Australia

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

4G Vaccines Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 15-Jun-2012 Cancelled Generating Revenue
4. Merger/Acquisition 01-Jan-2012 Completed Generating Revenue
3. Grant 01-Jan-2009 Completed Generating Revenue
2. Grant 01-Jan-2008 $372K Completed Generating Revenue
1. Early Stage VC 01-Nov-2006 Completed Generating Revenue
To view 4G Vaccines’s complete valuation and funding history, request access »

4G Vaccines Patents

  • 13

    Total Documents Applications and Grants

  • Total Patents Families

  • 1

    Granted

  • Pending

  • Expiring in next 12 mo

4G Vaccines Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2011904656-A0 Immunomodulatory conjugates Inactive 09-Nov-2011
AU-2011904659-A0 Targeted immunomodulation Inactive 09-Nov-2011
AU-2010904060-A0 Immunostimulatory and vaccine compositions Inactive 09-Sep-2010
AU-2010901997-A0 Immunostimulatory and vaccine compositions Inactive 10-May-2010
US-20130251741-A1 Immunostimulatory and vaccine compositions Active 10-May-2010 A61K39/39
To view 4G Vaccines’s complete patent history, request access »

4G Vaccines Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
SciVentures Investments Venture Capital Minority
To view 4G Vaccines’s complete investors history, request access »

Ready to get started?

Request a free trial

4G Vaccines FAQs

  • Where is 4G Vaccines headquartered?

    4G Vaccines is headquartered in Heidelberg, Australia.

  • What industry is 4G Vaccines in?

    4G Vaccines’s primary industry is Drug Discovery.

  • Is 4G Vaccines a private or public company?

    4G Vaccines is a Private company.

  • What is 4G Vaccines’s current revenue?

    The current revenue for 4G Vaccines is .

  • Who are 4G Vaccines’s investors?

    SciVentures Investments has invested in 4G Vaccines.

  • When was 4G Vaccines acquired?

    4G Vaccines was acquired on 15-Jun-2012.

  • Who acquired 4G Vaccines?

    4G Vaccines was acquired by Stamford Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process